Home › Funds › Two Sigma Investments › IBO
Two Sigma Investments position in IBO
IMPACT BIOMEDICAL INC · Health Care
Latest position (Q2 2026)17.19K sh
Reported value held$7.91K
Portfolio Weight0.00%
First reportedQ2 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 22.70K | $14.69K | New |
| Q2 2025 | 22.70K | $14.69K | New |
| Q3 2025 | 31.50K | $20.94K | Add |
| Q4 2025 | 39.83K | $20.11K | Add |
| Q1 2026 | 37.43K | $22.46K | Reduce |
| Q2 2026 | 17.19K | $7.91K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IBO
- Geode Capital Management 1.19M sh · $545.58K · Q2 2026
- Vanguard Group 814.88K sh · $411.52K · Q4 2025
- BlackRock Inc 259.95K sh · $119.58K · Q2 2026
- Northern Trust Corp 235.47K sh · $108.32K · Q2 2026
- Citadel Advisors 49.57K sh · $22.80K · Q2 2026
- Morgan Stanley 9.29K sh · $4.27K · Q2 2026
- UBS Group AG 2.40K sh · $1.10K · Q2 2026
- Fidelity Management & Research (FMR) 292 sh · $134 · Q2 2026
- Wells Fargo & Co 224 sh · $103 · Q2 2026
- Citigroup Inc 1 sh · $0 · Q2 2026